Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,022.00
Bid: 12,624.00
Ask: 11,284.00
Change: 34.00 (0.28%)
Spread: -1,340.00 (-10.615%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Cuts Travis Perkins To Underweight

Thu, 11th Aug 2016 08:35

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
BARCLAYS CUTS TRAVIS PERKINS TO 'UNDERWEIGHT' ('EQUALWEIGHT') - TARGET 1400 (1950) PENCE
----------
LIBERUM ADDS BRITISH LAND TO 'CONVICTION SELL LIST'
----------
COMMERZBANK CUTS EASYJET PRICE TARGET TO 1200 (1350) PENCE - 'HOLD'
----------
JPMORGAN CUTS RBS PRICE TARGET TO 175 (185) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS LLOYDS PRICE TARGET TO 62 (65) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BARCLAYS PRICE TARGET TO 175 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ROLLS ROYCE GROUP PRICE TARGET TO 835 (730) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES PEARSON PRICE TARGET TO 935 (905) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES BHP BILLITON PRICE TARGET TO 900 (885) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1378 (1324) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 5600 (5400) PENCE - 'BUY'
----------
HSBC CUTS ASTRAZENECA PRICE TARGET TO 4700 (4815) PENCE - 'HOLD'
----------
FTSE 250
----------
LIBERUM REMOVES TULLOW OIL FROM 'CONVICTION SELL LIST'
----------
PANMURE CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 168 (145) PENCE
----------
RBC CAPITAL RAISES CENTAMIN PRICE TARGET TO 190 (170) PENCE - 'SECTOR PERFORM'
----------
Numis Ups Centamin Target To 180p From 160p, Keeps Hold
----------
HSBC RAISES SEGRO PRICE TARGET TO 418 (378) PENCE - 'HOLD'
----------
HSBC CUTS BRITVIC PRICE TARGET TO 620 (640) PENCE - 'HOLD'
----------
Investec Ups Virgin Money Target To 375p From 360p, Keeps Buy
----------
Cantor Cuts Debenhams Target To 60p From 70p, Keeps Hold
----------
Liberum Ups Spirax-Sarco Target To 4,090p From 3,140p, Keeps Hold
----------
MORGAN STANLEY RAISES SPIRAX-SARCO TARGET TO 4080 (3570) PENCE - 'EQUAL-WEIGHT'
----------
S&P GLOBAL RAISES AMEC PRICE TARGET TO 600 (500) PENCE - 'BUY'
----------
TRADERS: CANACCORD CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY')
----------
BERENBERG RAISES INMARSAT PRICE TARGET TO 910 (880) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
RBC CAPITAL CUTS FAROE PETROLEUM PRICE TARGET TO 100 (120) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES INTERSERVE PRICE TARGET TO 425 (416) PENCE - 'OVERWEIGHT'
----------
finnCap Initiates Joules Group With Buy, Target At 200p
----------
Berenberg Ups Benchmark Holdings Target To 80p From 70p, Keeps Buy
----------
BERENBERG RAISES STOCK SPIRITS PRICE TARGET TO 150 (137) PENCE - 'HOLD'
----------
BERENBERG CUTS LOOKERS PRICE TARGET TO 170 (220) PENCE - 'BUY'
----------
BERENBERG RAISES GVC HOLDING PRICE TARGET TO 760 (730) PENCE - 'BUY'
----------
BERENBERG RAISES STAFFLINE TO 'BUY' ('HOLD') - TARGET 1250 (900) PENCE
----------
Numis Ups Breedon Aggregates to Add From Hold, Target To 82p From 70p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
25 Apr 2024 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.